白细胞及其亚型预测急性心肌梗死合并心源性休克的短期结局:一项队列研究
该队列研究纳入217例连续急性心肌梗死合并心源性休克患者,分析白细胞及其亚型对30天全因死亡(主要终点)和MACE复合终点(次要终点)的预测价值。结果显示,白细胞及中性粒细胞、嗜酸性粒细胞、淋巴细胞、单核细胞、嗜碱性粒细胞在存活者与死亡者间均有统计学差异(均P<0.05)。嗜酸性粒细胞对30天全因死亡的预测价值最高(AUC=0.799),白细胞及其亚型联合可提高预测效能(AUC=0.834)。多因素校正后,高白细胞(>11.6×10⁹/L)、低嗜酸性粒细胞(<0.3%)、低嗜碱性粒细胞(≤0.1%)均与30天死亡和MACE风险独立相关。提示这些指标应考虑纳入现有风险分层模型。
要点
- 在217例AMI合并心源性休克患者中,高白细胞(>11.6×10⁹/L)与30天死亡风险独立相关(HR 1.815;95%CI 1.134, 2.903;P=0.013)。
- 低嗜酸性粒细胞(<0.3%)与30天死亡风险独立相关(HR 2.562;95%CI 1.412, 4.648;P=0.002),为亚型中预测价值最高(AUC=0.799)。
- 低嗜碱性粒细胞(≤0.1%)与30天死亡风险独立相关(HR 1.694;95%CI 1.106, 2.592;P=0.015)。
- 白细胞及其亚型联合预测30天全因死亡的AUC为0.834,高于单一嗜酸性粒细胞(AUC=0.799)。
- 高白细胞、低嗜酸性粒细胞、低嗜碱性粒细胞亦与30天MACE风险独立相关(HR分别为1.894、1.729、1.560)。
适用人群与场景
- 连续217例急性心肌梗死合并心源性休克的患者。
- 原文未提及排除人群及具体急诊/ICU/院前场景。
诊断标准与关键阈值
- 原文未提及诊断标准与关键阈值(仅给出预后相关切点:白细胞>11.6×10⁹/L、嗜酸性粒细胞<0.3%、嗜碱性粒细胞≤0.1%,由Youden Index确定)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为队列研究,样本量217例,单中心(原文未明确中心数),人群为AMI合并心源性休克患者。
- 主要终点30天全因死亡:高白细胞(>11.6×10⁹/L)HR 1.815(95%CI 1.134, 2.903;P=0.013);低嗜酸性粒细胞(<0.3%)HR 2.562(95%CI 1.412, 4.648;P=0.002);低嗜碱性粒细胞(≤0.1%)HR 1.694(95%CI 1.106, 2.592;P=0.015)。
- 次要终点30天MACE:高白细胞HR 1.894(95%CI 1.285, 2.791;P=0.001);低嗜酸性粒细胞HR 1.729(95%CI 1.119, 2.670;P=0.014);低嗜碱性粒细胞HR 1.560(95%CI 1.101, 2.210;P=0.012)。
- 嗜酸性粒细胞对30天全因死亡的AUC=0.799,白细胞及其亚型联合AUC=0.834。
- 白细胞及亚型在存活者与死亡者间均有统计学差异(均P<0.05)。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未明确说明;设计上为单中心(原文未提及中心数)、观察性研究,样本量217例。
对床旁实践的改变
- 原文提示白细胞及其亚型(尤其是嗜酸性粒细胞和嗜碱性粒细胞)应考虑纳入当前AMI合并心源性休克的风险分层模型,可能改变风险分层实践。
- 适用人群:AMI合并心源性休克患者;不适用人群原文未提及。
- 常见陷阱原文未提及。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI) are at high risk of death. Inflammation is involved in both CS and AMI, and our present study aimed to investigate the changes of leukocyte and its subtypes as well as their prognostic value in patients with CS complicating AMI.
METHODS: Data of 217 consecutive patients with CS complicating AMI were analyzed. The primary endpoint was 30-day all-cause mortality. The secondary endpoint was the composite events of major adverse cardiovascular events (MACE) including 30-day all-cause mortality, ventricular tachycardia/ventricular fibrillation, atrioventricular block, gastrointestinal hemorrhage and nonfatal stroke. The association of leukocyte and its subtypes with the endpoints was analyzed by Cox regression analysis.
RESULTS: Leukocyte and its subtypes including neutrophil, eosinophil, lymphocyte, monocyte and basophil were all statistically significant between survivors and nonsurvivors (all P < 0.05). Among the leukocyte subtypes, eosinophil had the highest predictive value for 30-day all-cause mortality (AUC = 0.799) and the composite of leukocyte and its subtypes improved the predictive power (AUC = 0.834). The 30-day mortality and MACE K-M curves of leukocyte and its subtypes reveal a distinct trend based on the cut-off value determined by Youden Index (all log rank P < 0.001). After multivariable adjustment, high leukocyte (>11.6 × 109/L) (HR 1.815; 95%CI 1.134, 2.903; P = 0.013), low eosinophil (<0.3%) (HR 2.562; 95%CI 1.412, 4.648; P = 0.002) and low basophil (≤0.1%) (HR 1.694; 95%CI 1.106, 2.592; P = 0.015) were independently associated with increased risk of 30-day mortality. Similarly, high leukocyte (>11.6 × 109/L) (HR 1.894; 95%CI 1.285, 2.791; P = 0.001), low eosinophil (<0.3%) (HR 1.729; 95%CI 1.119, 2.670; P = 0.014) and low basophil (≤0.1%) (HR 1.560; 95%CI 1.101, 2.210; P = 0.012) were independently associated with increased risk of 30-day MACE.
CONCLUSIONS: Leukocyte and its subtypes changed significantly in patients with CS complicating AMI. In addition to leukocyte, eosinophil and basophil also served as independent prognostic factors for 30-day outcomes. Moreover, as the composite of leukocyte and its subtypes increased the predictive power, thus leukocyte and its subtypes, especially eosinophil and basophil should be taken into consideration for the current risk stratification model.
参考来源
- Sasmita BR, Zhu Y, Gan H, et al. Leukocyte and its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study. Shock. 2022. PMID: 34710884. doi:10.1097/SHK.0000000000001876
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。